Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dong-A ST Co., Ltd.
An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of DA-5230 With DA-5230-R in Healthy Adult Volunteers
Age
19–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy participants aged 19 to 55 years at the time of screening visit
Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
You may not be if
Participants who have received an investigational product in another clinical trial or a bioequivalence study within 6 months prior to the first dosing
Participants deemed unsuitable for participation in this clinical trial by the investigator